Cognitive enhancers for anxiety disorders

被引:43
作者
Hofmann, Stefan G. [1 ]
Smits, Jasper A. J. [2 ]
Asnaani, Anu [1 ]
Gutner, Cassidy A. [1 ]
Otto, Michael W. [1 ]
机构
[1] Boston Univ, Dept Psychol, Boston, MA 02215 USA
[2] So Methodist Univ, Dallas, TX 75275 USA
关键词
Cognitive enhancer; Anxiety; Fear; Cognitive-behavioral therapy; POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; FEAR-POTENTIATED STARTLE; PITUITARY-ADRENAL AXIS; DOPAMINE D-1 RECEPTOR; LONG-TERM-MEMORY; D-CYCLOSERINE; PREFRONTAL CORTEX; BEHAVIORAL THERAPY; PANIC DISORDER;
D O I
10.1016/j.pbb.2010.11.020
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Cognitive-behavioral therapy is an effective intervention for anxiety disorders. However, a significant number of people do not respond or only show partial response even after an adequate course of the treatment. Recent research has shown that the efficacy of the intervention can be improved by the use of cognitive enhancers that augment the core learning processes of cognitive-behavior therapy. This manuscript provides a review of the current state of cognitive enhancers for the treatment of anxiety disorders. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:275 / 284
页数:10
相关论文
共 146 条
[1]   Endogenous cortisol elevations are related to memory facilitation only in individuals who are emotionally aroused [J].
Abercrombie, HC ;
Speck, NS ;
Monticelli, RM .
PSYCHONEUROENDOCRINOLOGY, 2006, 31 (02) :187-196
[2]   Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction [J].
Airaksinen, E ;
Larsson, M ;
Forsell, Y .
JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (02) :207-214
[3]   The promise of extinction research for the prevention and treatment of anxiety disorders [J].
Anderson, Kathleen C. ;
Insel, Thomas R. .
BIOLOGICAL PSYCHIATRY, 2006, 60 (04) :319-321
[4]  
Aouizerate B, 2004, ENCEPHALE, V30, P301
[5]   Blockade of cannabinoid CB1 receptors alters contextual learning and memory [J].
Arenos, Jeremy D. ;
Musty, Richard E. ;
Bucci, David J. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 539 (03) :177-183
[6]   Adrenergic targets for the treatment of cognitive deficits in schizophrenia [J].
Arnsten, AFT .
PSYCHOPHARMACOLOGY, 2004, 174 (01) :25-31
[7]   ALPHA-2-ADRENERGIC MECHANISMS IN PREFRONTAL CORTEX ASSOCIATED WITH COGNITIVE DECLINE IN AGED NONHUMAN-PRIMATES [J].
ARNSTEN, AFT ;
GOLDMANRAKIC, PS .
SCIENCE, 1985, 230 (4731) :1273-1276
[8]  
ASMUNDSON GJG, 1994, ANXIETY, V1, P201
[9]   An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance [J].
Aston-Jones, G ;
Cohen, JD .
ANNUAL REVIEW OF NEUROSCIENCE, 2005, 28 :403-450
[10]   Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology [J].
Baldwin, DS ;
Anderson, IM ;
Nutt, DJ ;
Bandelow, B ;
Bond, A ;
Davidson, JRT ;
den Boer, JA ;
Fineberg, NA ;
Knapp, M ;
Scott, J ;
Wittchen, HU .
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (06) :567-596